Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivo von Jhaveri, Aakash V., Zhou, Lanlan, Ralff, Marie D., Lee, Young S., Navaraj, Arunasalam, Carneiro, Benedito A., Safran, Howard, Prabhu, Varun V., Ross, Eric A., Lee, Seulki, El-Deiry, Wafik S.

Volltext

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer von Rappaport, Jeffrey A., Entezari, Ariana A., Caspi, Adi, Caksa, Signe, Jhaveri, Aakash V., Stanek, Timothy J., Ertel, Adam, Kupper, Joan, Fortina, Paolo M., McMahon, Steven B., Jaynes, James B., Snook, Adam E., Waldman, Scott A.

Volltext

Abstract 6225: Addition of TRAIL receptor agonists after treatment with ONC201 or ONC212 converts pancreatic cancer cells from anti-proliferative to apoptotic in vitro von Jhaveri, Aakash V., Zhou, Lanlan, Ferarrini, Isacco, Lee, Young, El-Deiry, Wafik S.

Volltext

Abstract PO-064: ONC212 stimulates cytotoxic T-cell killing, increases tumor-immune cell interactions, and promotes tumor regression in combination with TLY012 in a PDAC murine mod... von Huntington, Kelsey E., Louie, Anna, Lee, Young, Mompoint, Jared, Ferrarini, Isacco, Jhaveri, Aakash, Prabhu, Varun V., Melemed, Allen, Lee, Seulki, El-Deiry, Wafik S.

Volltext